Skip to content
10-Q

Quarterly Report

Bio-En Holdings Corp.

0001410578-22-001622

← back to feed
Filed
May 16, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2022 · Mar 31, 2022 77.35M sh
Shares Diluted Q1 2022 · Mar 31, 2021 77.35M sh
Shares Outstanding Q1 2022 · Mar 31, 2022 77.35M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$13.95K
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$16.25K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $1.68K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $15.63K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$499.1K
Stockholders Equity Q1 2022 · Dec 31, 2021 −$484.62K
Current Liabilities Q1 2022 · Mar 31, 2022 $500.78K
Current Liabilities Q1 2022 · Dec 31, 2021 $500.25K
Total Liabilities Q1 2022 · Mar 31, 2022 $500.78K
Total Liabilities Q1 2022 · Dec 31, 2021 $500.25K
Current Assets Q1 2022 · Mar 31, 2022 $1.68K
Current Assets Q1 2022 · Dec 31, 2021 $15.63K
Total Assets Q1 2022 · Mar 31, 2022 $1.68K
Total Assets Q1 2022 · Dec 31, 2021 $15.63K
Eps Diluted Q1 2022 · Mar 31, 2022 $0.00
Eps Diluted Q1 2022 · Mar 31, 2021 $0.00
Eps Basic Q1 2022 · Mar 31, 2022 $0.00
Eps Basic Q1 2022 · Mar 31, 2021 $0.00
Net Income Q1 2022 · Mar 31, 2022 −$14.48K
Net Income Q1 2022 · Mar 31, 2021 −$13.55K
Operating Income Q1 2022 · Mar 31, 2022 −$15.48K
Operating Income Q1 2022 · Mar 31, 2021 −$13.55K
Revenue Q1 2022 · Mar 31, 2022 $0